Biocon is addressing global medical needs through a portfolio of differentiated and high quality, life-saving biotherapeutics. We have used innovative science to bring competition for some of the world’s most expensive medicines through our generics and biosimilars, thus enabling affordable access to advanced therapies for millions of patients with chronic conditions across the globe. At the same time, we are ensuring that a larger number of patients are able to access generic versions of drugs like statins and immunosupressants by supplying our high quality APIs to drug makers worldwide.